3SOF

in 1.12

       

Press Release Source: Lev Pharmaceuticals, Inc.


Lev Pharmaceuticals to Present at the BIO CEO & Investor Conference
Wednesday February 6, 7:05 am ET


NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP.OB - News) announced today that Joshua Schein, Ph.D., Chief Executive Officer of Lev will present at the BIO CEO & Investor Conference 2008, being held February 11-13 at the Waldorf Astoria in New York City. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ (C1 inhibitor). The Lev presentation is scheduled to begin at 10:15 AM ET on Tuesday, February 12th.


The Lev presentation will be webcast live and may be accessed by visiting the Investor Relations section of the company website at www.levpharma.com. The 40-minute presentation will also be available on the Lev website in replay format for a limited time following the conference.

About Lev Pharmaceuticals, Inc.

I like simply fo rthe rebound/gap fill play...nibbled a little @ $1.15

nice fwhp that you join me...up 9.17% today on a bearish day...great sign

http://seekingalpha.com/article/63789-lev-pharmaceutical-bullish-despite-delayed-fda-decision?source=yahoo

Updated chart: